Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-03

Clinical Trial Update: Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the clinical benefit and safety of droxidopa in Parkinson's disease with freezing of gait; the study status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Droxidopa (Droxidopa)

Snippet

Sponsor: Henry Ford Health System | Conditions: Parkinson's Disease, Freezing of Gait | Phase 2 | Status: UNKNOWN